FORMULIERUNG EINES NEUARTIGEN BISPEZIFISCHEN ANTI-CD3/CD20-POLYPEPTIDKOMPLEXES

Patent europeic · EP4190352 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4190352
Numer da la dumonda
EP21849910
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-07-2021
Publitgà
07-06-2023
Concedì
25-03-2026
La protecziun finescha il pli tard
25-07-2041
Proxima taxa annuala scadenta
31-07-2026
Classas IPC
A61K 9/00 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
A61K 9/08 (2006.01)
A61K 9/19 (2006.01)
A61K 47/12 (2006.01)
A61K 47/18 (2017.01)
A61K 39/00 (2006.01)
C07K 16/28 (2006.01)
Prioritad
CN 202010733597 27.07.2020
Dumonda PCT
PCT/CN2021/108455 26.07.2021
Publicaziun PCT
WO2022/022464 03.02.2022
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.03.2026

Partidas

Inventur

ZHU, Youwei

Lianyungang, Jiangsu 222062, CN

LI, Yingchun

Lianyungang, Jiangsu 222062, CN

CHENG, Yanju

Lianyungang, Jiangsu 222062, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.